Lilian Alcaraz
Corporate Officer/Principal presso Pulmagen Therapeutics (Synergy) Ltd.
Posizioni attive di Lilian Alcaraz
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Corporate Officer/Principal | - | - |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investitore di Private Equity | 01/03/2021 | - |
Storia della carriera di Lilian Alcaraz
Formazione di Lilian Alcaraz
| Universite Louis Pasteur Strasbourg I | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
| Regno Unito | 2 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Settori
| Finance | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Lilian Alcaraz
- Esperienza
